Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

32.22

-0.05 (-0.15%)

Sep 25, 2026, 11:22 AM EDT - Market open

Caris Life Sciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	989.61	812.03	412.26	306.13	258.49
Revenue Growth	85.37%	96.97%	34.67%	18.43%	-
Gross Profit	691.23	541.04	180.43	91.26	80.02
Operating Income	153.26	45.11	-257.12	-319.55	-315.76
Net Income	105.14	-537.96	-378.26	-462.53	-399.83
Earnings Per Share	0.37	-3.22	-10.66	-13.24	-11.98
EPS Growth	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Molecular Profiling Services	952.77	766.72	349.12	278.75	238.6	181.5
Pharma Research and Development Services	36.84	45.31	63.15	27.38	19.9	10.8
Revenue (Total)	989.61	812.03	412.26	306.13	258.49	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	793.12	798.57	66.15	121.59	409.62
Total Debt	452.4	427.69	424.26	217.11	270.87
Net Cash (Debt)	340.71	370.88	-358.11	-95.52	138.75
Net Cash Growth	12.74%	-	-	-	-
Net Cash Per Share	1.20	2.22	-10.09	-2.73	4.16

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	168.56	83.16	-245.2	-276.1	-285.71
Capital Expenditures	-44.6	-16.26	-8.44	-22.32	-42.26
Free Cash Flow	123.96	66.9	-253.64	-298.42	-327.96
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	69.85%	66.63%	43.77%	29.81%	30.96%
Operating Margin	15.49%	5.56%	-62.37%	-104.38%	-122.16%
Pretax Margin	10.61%	-8.38%	-68.38%	-111.53%	-124.12%
Profit Margin	10.62%	-66.25%	-91.75%	-151.09%	-154.68%
FCF Margin	12.53%	8.24%	-61.52%	-97.48%	-126.88%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Forward PE	114.76	294.73	-	-	-
P/FCF Ratio	73.30	113.80	-	-	-
PS Ratio	9.18	9.37	-	-	-